Transcriptional CDK Inhibitors Emerge as Dual Weapons Against Bone Metastases
A new review argues that transcriptional CDK inhibitors, especially CDK9 blockers, could simultaneously target oncogenic transcription in metastatic tumor cells ...
A new review argues that transcriptional CDK inhibitors, especially CDK9 blockers, could simultaneously target oncogenic transcription in metastatic tumor cells ...
A new iScience study shows that combining a selective CDK9 inhibitor with a PP2A-activating drug durably silences HIV transcription in ...
Boston Children's Hospital researchers discovered that the metabolic enzyme FAH moves into the nucleus of breast cancer cells and drives ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine